E I D-Parry (India) Ltd
NSE:EIDPARRY
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
542.15
981.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
E I D-Parry (India) Ltd
E I D-Parry (India) Ltd
Income from Continuing Operations
E I D-Parry (India) Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
E I D-Parry (India) Ltd
NSE:EIDPARRY
|
Income from Continuing Operations
₹15.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
21%
|
CAGR 10-Years
18%
|
|
|
UPL Ltd
NSE:UPL
|
Income from Continuing Operations
-₹28B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fertilisers And Chemicals Travancore Ltd
NSE:FACT
|
Income from Continuing Operations
₹1.5B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Bayer Cropscience Ltd
NSE:BAYERCROP
|
Income from Continuing Operations
₹7.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
PI Industries Ltd
NSE:PIIND
|
Income from Continuing Operations
₹17.5B
|
CAGR 3-Years
31%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Coromandel International Ltd
NSE:COROMANDEL
|
Income from Continuing Operations
₹13.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
E I D-Parry (India) Ltd
Glance View
In the bustling world of agribusiness, E I D-Parry (India) Ltd. emerges as a formidable player deeply rooted in the agricultural heartland of India. Founded in 1788, the company has evolved over two centuries to become a significant name in the sugar and nutraceutical arenas. At the core of its operations lies the sugar production segment, which remains a substantial contributor to its revenue stream. Encompassing sugarcane cultivation, processing, and refined sugar production, E I D-Parry leverages extensive expertise and technological advancements to maintain efficiency. By investing in integrated factories, which include state-of-the-art distilleries and cogeneration plants, the company optimizes its byproducts, efficiently producing ethanol and generating power for the grid. This approach not only maximizes profit margins but also underscores a commitment to sustainability. Beyond the traditional sugar business, E I D-Parry takes strides into the growing nutraceutical market, sensing the opportunity to capitalize on the increasing global wellness trend. Through its subsidiary, Parry Nutraceuticals, the company delves into the extraction and commercialization of high-value health supplements, such as spirulina and microalgae. This diversification is not only a hedge against the volatile sugar market but also a step towards leveraging its expertise in fermentation technology. By strategically expanding its portfolio and tapping into value-added products, E I D-Parry crafts a multifaceted business model that stays resilient amid cyclical agricultural dynamics, positioning itself as a forward-thinking entity in both local and international markets.
See Also
What is E I D-Parry (India) Ltd's Income from Continuing Operations?
Income from Continuing Operations
15.2B
INR
Based on the financial report for Jun 30, 2024, E I D-Parry (India) Ltd's Income from Continuing Operations amounts to 15.2B INR.
What is E I D-Parry (India) Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
18%
Over the last year, the Income from Continuing Operations growth was -8%. The average annual Income from Continuing Operations growth rates for E I D-Parry (India) Ltd have been 10% over the past three years , 21% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet